Vertex Pharmaceuticals Inc. buy BMO Capital Markets
Start price
05.08.25
/
50%
€349.95
Target price
05.08.26
€458.50
Performance (%)
18.32%
Price
13.02.26
€414.05
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 18.32%. This prediction currently runs until 05.08.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.412% | 2.412% |
| iShares Core DAX® | 0,46 % | -2,00 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % |
| iShares S&P 500 | -1,76 % | -3,67 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at BMO Capital Markets from $557.00 to $530.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.90
20.12.24
20.12.24
€498.52
20.12.25
20.12.25
2.55%
21.12.25
21.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€413.40
31.05.24
31.05.24
€459.80
31.05.25
31.05.25
-6.79%
01.06.25
01.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.80
07.11.23
07.11.23
€388.11
07.11.24
07.11.24
30.65%
08.11.24
08.11.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.35
02.08.23
02.08.23
€355.55
02.08.24
02.08.24
35.94%
03.08.24
03.08.24